LYZ and non-Hodgkin lymphoma: HS is diagnosed using positive immunohistochemistry for histiocytic markers, such as CD68, CD4, CD163, or lysozyme, and can present in an isolated form or be associated with other hematologic malignancies, such as non-Hodgkin lymphoma (NHL) or acute leukemia (2–4).